04.09.2017
- US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...
23.08.2017
- South Korean biopharmaceutical company Samsung Bioepis is taking its first step into novel drug development with an agreement to partner Japan’s Takeda Pharmaceutical. The move...
22.08.2017
- Monsanto has signed a global licensing agreement with South Korean biotech ToolGen, gaining access to its CRISPR gene-editing technology. Financial terms were not disclosed. "This...
13.06.2017
- The European Commission has approved plans by US healthcare group Johnson & Johnson to acquire Swiss biotech Actelion, thus completing all global regulatory approvals. J&J said it...
01.06.2017
- UK biotech Bicycle Therapeutics has raised £40 million from a Series B financing round to advance the development of multiple candidate drugs to treat cancers with a high unmet...
01.06.2017
- A new report released by the UK BioIndustry Association (BIA) showed that the UK received the highest amount of biotech funding compared to anywhere else in Europe last year, and...
19.05.2017
- Biogen has licensed a late-stage stroke drug from Remedy Pharmaceuticals. The US biotech will make an upfront payment of $120 million for Cirara (intravenous glyburide), as well as...
08.05.2017
- South Africa’s competition commission has conditionally approved Bayer’s plan to acquire Monsanto, thus becoming the first antitrust authority to do so. It will require divestments...
